ORBIMED ADVISORS LLC Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$8.8B
Holdings
131
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (131 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXNALEXION PHARMACEUTICALS INC | 3,760,986 | $456.0B | 5168.57% | Call |
| 2 | BIIBBIOGEN INC | 1,436,900 | $392.9B | 4453.27% | |
| 3 | CELGCELGENE CORP | 3,132,177 | $389.7B | 4417.68% | |
| 4 | BSXBOSTON SCIENTIFIC CORP | 15,311,400 | $380.8B | 4316.33% | |
| 5 | MRKMERCK & CO INC | 5,714,900 | $363.1B | 4116.03% | |
| 6 | —WRIGHT MED GROUP N V | 9,196,234 | $286.2B | 3243.94% | Call |
| 7 | LLYLILLY ELI & CO | 3,330,200 | $280.1B | 3174.98% | |
| 8 | INCYINCYTE CORP | 1,973,597 | $263.8B | 2990.31% | |
| 9 | VRTXVERTEX PHARMACEUTICALS INC | 2,169,200 | $237.2B | 2688.69% | |
| 10 | AMGNAMGEN INC | 1,438,300 | $236.0B | 2674.86% | |
| 11 | AG8AGILENT TECHNOLOGIES INC | 3,629,900 | $191.9B | 2175.34% | |
| 12 | PFEPFIZER INC | 5,406,100 | $184.9B | 2096.34% | |
| 13 | EWEDWARDS LIFESCIENCES CORP | 1,839,300 | $173.0B | 1961.22% | |
| 14 | —AETNA INC NEW | 1,312,400 | $167.4B | 1897.45% | |
| 15 | —SHIRE PLC | 897,451 | $156.4B | 1772.38% | |
| 16 | HCAHCA HOLDINGS INC | 1,745,000 | $155.3B | 1760.20% | |
| 17 | HUMHUMANA INC | 742,300 | $153.0B | 1734.46% | |
| 18 | REGNREGENERON PHARMACEUTICALS | 378,170 | $146.5B | 1661.09% | |
| 19 | ELVANTHEM INC | 862,600 | $142.7B | 1617.02% | |
| 20 | ABBVABBVIE INC | 2,080,000 | $135.5B | 1536.27% | |
| 21 | ARRYEURARRAY BIOPHARMA INC | 14,182,900 | $126.8B | 1437.23% | |
| 22 | IRWDIRONWOOD PHARMACEUTICALS INC | 7,241,300 | $123.5B | 1400.30% | |
| 23 | BMYBRISTOL MYERS SQUIBB CO | 2,211,000 | $120.2B | 1362.86% | Put |
| 24 | CNCCENTENE CORP DEL | 1,655,700 | $118.0B | 1337.36% | |
| 25 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 1,037,000 | $117.3B | 1329.43% | |
| 26 | —ALLERGAN PLC | 477,390 | $114.1B | 1292.85% | |
| 27 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,274,100 | $111.8B | 1267.71% | |
| 28 | CRVSCORVUS PHARMACEUTICALS INC | 5,379,349 | $111.7B | 1266.45% | |
| 29 | JNJJOHNSON & JOHNSON | 884,600 | $110.2B | 1248.86% | |
| 30 | —SYNERGY PHARMACEUTICALS DEL | 21,153,343 | $98.6B | 1117.35% | |
| 31 | THCTENET HEALTHCARE CORP | 5,352,000 | $94.8B | 1074.38% | |
| 32 | GKOSGLAUKOS CORP | 1,741,700 | $89.3B | 1012.77% | |
| 33 | IM8NINSMED INC | 4,810,905 | $84.2B | 954.85% | |
| 34 | PBYIPUMA BIOTECHNOLOGY INC | 2,245,925 | $83.5B | 947.02% | |
| 35 | TMOTHERMO FISHER SCIENTIFIC INC | 534,200 | $82.1B | 930.07% | |
| 36 | —AUDENTES THERAPEUTICS INC | 4,801,638 | $81.8B | 927.43% | |
| 37 | VRAYQVIEWRAY INC | 9,458,567 | $80.5B | 912.38% | |
| 38 | ASNDASCENDIS PHARMA A S | 2,717,315 | $76.1B | 862.43% | |
| 39 | —MAGELLAN HEALTH INC | 1,088,727 | $75.2B | 852.13% | |
| 40 | —ALLERGAN PLC | 88,200 | $74.8B | 848.22% | |
| 41 | —LOXO ONCOLOGY INC | 1,728,000 | $72.7B | 824.22% | |
| 42 | AERIEURAERIE PHARMACEUTICALS INC | 1,496,000 | $67.8B | 769.01% | |
| 43 | —MALLINCKRODT PUB LTD CO | 1,472,700 | $65.6B | 744.01% | |
| 44 | INSYEURINSYS THERAPEUTICS INC NEW | 6,071,440 | $63.8B | 723.30% | |
| 45 | MDTMEDTRONIC PLC | 766,600 | $61.8B | 700.02% | |
| 46 | —GW PHARMACEUTICALS PLC | 475,900 | $57.6B | 652.39% | |
| 47 | EGRXEAGLE PHARMACEUTICALS INC | 671,000 | $55.7B | 630.83% | |
| 48 | —ACHILLION PHARMACEUTICALS IN | 13,107,200 | $55.2B | 625.48% | |
| 49 | ILMNILLUMINA INC | 321,900 | $54.9B | 622.62% | |
| 50 | GILDGILEAD SCIENCES INC | 800,900 | $54.4B | 616.59% | |
| 51 | JAZZJAZZ PHARMACEUTICALS PLC | 371,400 | $53.9B | 610.97% | |
| 52 | —NEWLINK GENETICS CORP | 2,191,700 | $52.8B | 598.72% | Call |
| 53 | —MYLAN N V | 1,300,000 | $50.7B | 574.54% | |
| 54 | UNHUNITEDHEALTH GROUP INC | 296,400 | $48.6B | 551.03% | |
| 55 | —IMMUNOMEDICS INC | 30,000,000 | $42.3B | 479.03% | |
| 56 | SYKSTRYKER CORP | 316,300 | $41.6B | 472.00% | |
| 57 | ACADACADIA PHARMACEUTICALS INC | 1,169,000 | $40.2B | 455.56% | |
| 58 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,084,500 | $40.0B | 452.99% | |
| 59 | ISRGINTUITIVE SURGICAL INC | 50,400 | $38.6B | 437.87% | |
| 60 | COOCOOPER COS INC | 190,800 | $38.1B | 432.31% | |
| 61 | NTLAINTELLIA THERAPEUTICS INC | 2,662,180 | $37.5B | 425.18% | |
| 62 | —DERMIRA INC | 1,023,673 | $34.9B | 395.79% | |
| 63 | ONCBEIGENE LTD | 903,700 | $33.1B | 375.01% | |
| 64 | ASMBASSEMBLY BIOSCIENCES INC | 1,257,300 | $32.0B | 363.28% | |
| 65 | SRPTSAREPTA THERAPEUTICS INC | 1,054,300 | $31.2B | 353.73% | |
| 66 | —MOMENTA PHARMACEUTICALS INC | 2,109,068 | $28.2B | 319.15% | |
| 67 | SEMSELECT MED HLDGS CORP | 2,086,300 | $27.9B | 315.70% | |
| 68 | —RADIUS HEALTH INC | 704,100 | $27.2B | 308.46% | |
| 69 | —OBSEVA SA | 2,605,531 | $27.1B | 307.45% | |
| 70 | SELBUSDSELECTA BIOSCIENCES INC | 1,842,797 | $26.4B | 299.12% | |
| 71 | —BLUEBIRD BIO INC | 283,800 | $25.8B | 292.41% | |
| 72 | —LION BIOTECHNOLOGIES INC | 3,382,900 | $25.2B | 285.68% | |
| 73 | GLPGGALAPAGOS NV | 283,500 | $24.4B | 276.97% | |
| 74 | IMGNEURIMMUNOGEN INC | 6,095,647 | $23.6B | 267.39% | |
| 75 | CHRSCOHERUS BIOSCIENCES INC | 1,084,400 | $22.9B | 259.97% | |
| 76 | OTICEUROTONOMY INC | 1,850,094 | $22.7B | 256.90% | |
| 77 | EHTHEHEALTH INC | 1,820,000 | $21.9B | 248.38% | |
| 78 | —NABRIVA THERAPEUTICS AG | 1,677,940 | $20.1B | 228.23% | |
| 79 | XNCRXENCOR INC | 840,237 | $20.1B | 227.81% | |
| 80 | NBIXNEUROCRINE BIOSCIENCES INC | 441,341 | $19.1B | 216.61% | |
| 81 | PIRSPIERIS PHARMACEUTICALS INC | 7,259,620 | $18.9B | 213.95% | |
| 82 | —DBV TECHNOLOGIES S A | 512,900 | $18.1B | 204.76% | |
| 83 | —STEADYMED LTD | 3,072,196 | $17.8B | 201.98% | |
| 84 | SVASINOVAC BIOTECH LTD | 2,667,500 | $15.3B | 173.26% | |
| 85 | BCRUSDBARD C R INC | 58,000 | $14.4B | 163.39% | |
| 86 | EXASEXACT SCIENCES CORP | 602,900 | $14.2B | 161.41% | |
| 87 | TEVATEVA PHARMACEUTICAL INDS LTD | 412,600 | $13.2B | 150.08% | |
| 88 | AUPHAURINIA PHARMACEUTICALS INC | 1,797,400 | $13.2B | 149.54% | |
| 89 | —AEGERION PHARMACEUTICALS INC | 15,000,000 | $12.3B | 139.61% | |
| 90 | PRQRPROQR THRAPEUTICS N V | 2,305,446 | $11.5B | 130.66% | |
| 91 | NTRANATERA INC | 1,276,190 | $11.3B | 128.31% | |
| 92 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,469,524 | $10.9B | 124.10% | |
| 93 | —WRIGHT MED GROUP N V | 6,900,000 | $10.6B | 119.68% | |
| 94 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 1,914,660 | $10.6B | 119.58% | |
| 95 | INFIQINFINITY PHARMACEUTICALS INC | 3,250,300 | $10.5B | 119.00% | |
| 96 | FLBFLUIDIGM CORP DEL | 1,746,100 | $9.9B | 112.61% | |
| 97 | HRTXHERON THERAPEUTICS INC | 650,000 | $9.8B | 110.52% | |
| 98 | —DIMENSION THERAPEUTICS INC | 5,397,698 | $9.4B | 107.07% | |
| 99 | NUVAGBPNUVASIVE INC | 123,500 | $9.2B | 104.54% | |
| 100 | ALKSALKERMES PLC | 145,000 | $8.5B | 96.16% |
Page 1 of 2Next